Huons BioPharma

Activity by year

202120222023202420252026

ContractExpansion

Jul 25, 2023EXPANSIONJecheon Industrial Complex No. 1, Jecheon, South Korea, South Korea$53.0Mops 2024
Huons Biopharma breaks ground on $53M botulinum toxin plant in Jecheon
Huons Biopharma held a groundbreaking ceremony for its third plant at Jecheon Industrial Complex No. 1, investing 70 billion won (approx. $53 million) to expand production capacity for its botulinum toxin product Liztox. The plant is expected to be completed by 2024.
Huons BioPharma #Medical Devices globalnewsagency.kr
Oct 26, 2021CONTRACTGermany$83.4M
Huons BioPharma signs $83.4M Hutox supply deal with Haemato Pharm
Huons BioPharma signed a deal potentially worth 97.2 billion won ($83.4 million) with Germany's Haemato Pharm to supply its Hutox botulinum toxin for sale in 29 European countries. The deal includes clinical trials in Europe, with marketing expected to begin in 2025.
Huons BioPharma Haemato Pharm customer #Medical Devices koreajoongangdaily.com

Site	Largest	Latest
Jecheon Industrial Complex No. 1, South Korea	$53.0M	2023-07-25

Customers

Loading…